Boston Globe (Free subscription) | 01/12/2008
Medical device maker Boston Scientific Corp. spent $410,000 lobbying the federal government in the third quarter on health care issues, according to a disclosure form.
Boston Globe (Free subscription) | yesterday
The chief executive of Boston Scientific said Tuesday it is unclear when involuntary selling by the medical device company's founders will stop.
Boston Globe (Free subscription) | 20/11/2008
As shares of Boston Scientific Corp. traded at their lowest value in more than 13 years, a UBS analyst began coverage with a "Buy" rating, due to the price and the company's cost cuts.
The Boston Business Journal (Free subscription) | 10/11/2008
Boston Scientific Corp. has received U.S. Food and Drug Administration approval to market its Apex dilation catheter. (BSX)
Law Blog - WSJ.com (Free subscription) | 24/10/2008
Boston Scientific Corp., finally free of a three-year moratorium on new products imposed by the U.S. Food and Drug Administration, said it received approval for a new stent to lessen the risk of strokes.
Seeking Alpha China (Free subscription) | 22/10/2008
Boston Scientific Corporation (BSX) Q3 FY08 Earnings Call Complete Story ยป
24/7 Wall St. (Free subscription) | 22/10/2008
Today after the close, SEC Filings have shown that Boston Scientific Corp. (NYSE: BSX) co-founders have been forced to sell more common stock to meet margin... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Market Watch (Free subscription) | 21/10/2008
SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. said late Tuesday that its third-quarter loss narrowed to $62 million, or 4 cents a share, from $272 million, or 18 cents a share, in the year-ago period. Excluding one-time items, the company would have reported earnings of 16 cents a share in the latest quarter. Revenue fell to $1.98 billion from $2.05 billion last year. Analysts...
Globe and Mail (Free subscription) | 21/11/2008
... given that the company has seen ever-dwindling revenues from its partnership with U.S.-based Boston Scientific Corp. in the production of drug-eluting stents.Angiotech announced plans in July to create the new subsidiary, which would not include assets related to the Taxus stent used in heart surgery to prop open coronary arteries.The coating process developed by Angiotech reduced...
Star Tribune (Free subscription) | 19/11/2008
... 13 percent to $724 million in the quarter, analysts said Medtronic lost market share to rivals Boston Scientific Corp., with operations in Arden Hills, and Little Canada-based St. Jude Medical Inc.
WBJournal.com (Free subscription) | 10/11/2008
Natick's Boston Scientific Corp. says it has received FDA approval for a new catheter designed to help patients with hard-to-treat hardening arteries.
Reuters UK (Free subscription) | 10/11/2008
... likely to come as welcome news for the four companies that sell lucrative drug-coated stents -- Boston Scientific Corp, Johnson & Johnson, Medtronic Inc and Abbott Laboratories -- following recent studies that found they may be used more often than necessary.The study should also provide some reassurance following smaller trials that cast doubt on the safety of drug coated stents."Previous...
Reuters (Free subscription) | 10/11/2008
... likely to come as welcome news for the four companies that sell lucrative drug-coated stents -- Boston Scientific Corp, Johnson & Johnson, Medtronic Inc and Abbott Laboratories -- following recent studies that found they may be used more often than necessary.The study should also provide some reassurance following smaller trials that cast doubt on the safety of drug coated stents."Previous...
Star Tribune (Free subscription) | 01/11/2008
... program has been with American Express since 1996; Northwest's is with U.S. Bank.BLOOMBERG NEWSBoston Scientific sells 60,000 shares Margin calls forced Boston Scientific Corp. co-founder and chairman Peter Nicholas to sell 60,000 more shares of company stock, according to a regulatory filing Friday. Nicholas sold the shares, owned by a limited partnership, on Wednesday for...
WBJournal.com (Free subscription) | 24/10/2008
Boston Scientific Corp. of Natick announced that it has received approval from the U.S. Food and Drug Administration for a carotid artery stent.
